Interleukin-18(IL-18) and Atherosclerosis

被引:0
|
作者
Givtaj, Nozar [1 ]
Bassiri, Hossein Ali [1 ]
Givtaj, Nader [1 ]
Simin, Asghar [1 ]
Noohi, Feridoun [1 ]
机构
[1] Univ Tehran Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
来源
IRANIAN HEART JOURNAL | 2012年 / 13卷 / 01期
关键词
Inflammation; Atherosclerosis; Interleukin; 18; CAD; Cytokine;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background- Atherosclerosis is a dynamic and progressive disease arising from the combination of endothelial dysfunction and inflammation. So, inflammatory mediators are important causative and progressive factors in atherosclerosis. Interleukin-18 (IL-18) is a pleiotropic cytokine which may have a key role in atherosclerosis, because the results of recent studies indicated that IL-18, either directly as a pro-inflammatory factor or indirectly as an interferon inducing factor, has central role in the inflammatory cascade. In present study, we evaluated the relation between blood concentration of IL-18 with atherosclerosis and its severity and also the relation of this cytokine with the other known risk factors of coronary artery disease (CAD). Methods- 138 patients who underwent diagnostic cardiac catheterization and had the inclusion criteria for this study, were selected. In the beginning, a questionnaire containing personal information and medical history was completed for each of them and blood samples were collected 24 hours before catheterization. We measured blood level of IL-18 and CRP in all samples. The results of these tests and the angiography were entered in the questionnaire and then information was analyzed using regression analyzing, K2 and statistical T test. P values of <0.05 were considered statistically significant. Results- By using the results of angiography, patients were divided in two groups. 1-Control group or normal coronary arteries (32 people) 2- Case group (106 people) or patients who were suffering from CAD. In second group, 6 patients (5.6%) had minimal CAD, 44 patients (41.5%) had single-vessel disease (SVD), 27 patients (25.4%) had 2VD and 29 patients (27.5%) had 3VD. In the laboratory tests, the mean IL-18 blood level in patients with CAD was 258.1 pgr/ml but in normal coronary arteries group it was 216.6 pgr/ml. The average blood level of IL-18 in patients who had minimal CAD was 235.5 pgr/ml, in SVD was 247.2 pgr/ml, in 2VD was 263.7 pgr/ml and in patients with 3VD was 274.1 pgr/ml. Also average CRP blood level in normal group was 8.9 mgr/L while in patients with CAD it was 20.4 mgr/L. Conclusion- The results of this study indicated that there was a direct and significant correlation between blood IL-18 level with existence (P<0.001) and severity of CAD (P<0.01) and IL-18 can be an independent predictor risk factor of atherosclerosis.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [31] TNF and interleukin-18 (IL-18) upregulation in kidneys and sera of patients with active systemic lupus erythematosus
    Aringer, M.
    McInnes, I. B.
    Steiner, G.
    Soleiman, A.
    Stocki-Hiesleitner, S.
    Hoefler, E.
    Meyer, B.
    UIrich, W.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 108 - 108
  • [32] INTERLEUKIN-18 (IL-18) PROMOTER POLYMORPHISM IN RELATION TO GENDER OF PATIENTS TREATED WITH INTERMITTENT HEMODIALYSIS (HD)
    Grzegorzewska, A. E.
    Wobszal, P.
    Jagodzinski, P. P.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2011, 34 (08): : 674 - 675
  • [33] The therapeutic potential of Interleukin-18 (IL-18) blocking antibodies in Graft Versus Host Disease (GVHD)
    Nagler, A
    Novick, D
    Ohana, M
    Zecchina, G
    Dinarello, CA
    Barak, V
    BONE MARROW TRANSPLANTATION, 2001, 27 : S77 - S77
  • [34] Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma
    Afsar, CIgdem Usul
    Karabulut, Mehmet
    Karabulut, Senem
    Alis, Halil
    Gonenc, Murat
    Dagoglu, Nergiz
    Serilmez, Murat
    Tas, Faruk
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (04) : 196 - 200
  • [35] Potential role of interleukin-18 (IL-18) in the development of local and systemic complications in acute pancreatitis.
    Rau, B
    Baumgart, K
    Paszkowski, AS
    Mayer, JM
    Beger, HG
    GASTROENTEROLOGY, 2000, 118 (04) : A164 - A164
  • [36] Stimulation of Mesangial Cells by Angiotensin II and Lipopolysaccharide Increases Expression of Interleukin-18, but Not IL-18 Receptor
    Hardy, Jayne
    Hambly, Brett
    Ko, Hongda
    Wyburn, Kate
    Eris, Josette
    Yin, Jianlin
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2010, 116 (04): : E63 - E71
  • [37] Reduced incidence and severity of collagen-induced arthritis in mice lacking interleukin-18 (IL-18).
    Leung, BP
    Wei, XQ
    Arthur, H
    Gracie, A
    Robertson, S
    Liew, FY
    McInnes, IB
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S176 - S176
  • [38] Evidence for the expression of interleukin (IL)-18, IL-18 receptor and IL-18 binding protein in the human endometrium
    Yoshino, O
    Osuga, Y
    Koga, K
    Tsutsumi, O
    Yano, T
    Fujii, T
    Kugu, K
    Momoeda, M
    Fujiwara, T
    Tomita, K
    Taketani, Y
    MOLECULAR HUMAN REPRODUCTION, 2001, 7 (07) : 649 - 654
  • [39] Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice
    Pasquali, P
    Adone, R
    Gasbarre, LC
    Pistoia, C
    Ciuchini, F
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (02) : 491 - 492
  • [40] Interleukin 18 (IL-18) as a target for immune intervention
    Wawrocki, Sebastian
    Druszczynska, Magdalena
    Kowalewicz-Kulbat, Magdalena
    Rudnicka, Wieslawa
    ACTA BIOCHIMICA POLONICA, 2016, 63 (01) : 59 - 63